Vesicle inhibition reduces <i>Candida</i> biofilm resistance
<i>Candida</i> biofilm matrix components are delivered to the extracellular space by vesicles where they deposit and confer biofilm-associated drug resistance. Here, we present evidence that drugs designed to inhibit mammalian exosome production exhibit similar effects on <i>C. albicans</i> extracellular vesicles<i>,</i> ultimately eliminating biofilm matrix assembly. We find that vesicle reduction renders biofilm communities susceptible to the antifungal fluconazole. Our findings argue that vesicle trafficking pathways represent a promising target to optimize for recalcitrant fungal biofilms.
Authors
- Jeniel E. Nett (ORCID: https://orcid.org/0000-0001-8587-6244)
- Ryley Jones
- David R. Andes (ORCID: https://orcid.org/0000-0002-7927-9950)
- Robert Żarnowski (ORCID: https://orcid.org/0000-0001-6343-1500)
- Min-Ju Kim (ORCID: https://orcid.org/0000-0002-7383-743X)
Institutions
- University of Wisconsin–Madison (US)
- William S. Middleton Memorial Veterans Hospital (US)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1128/aac.00045-25
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- National Institute of Allergy and Infectious Diseases